Alec Saitman, Ph.D.

  • Associate Professor of Pathology & Laboratory Medicine, School of Medicine
  • Director, Clinical Chemistry and Toxicology

Biography

Dr. Saitman's research focuses on the development of small molecule quantitation assays using mass spectrometry. His areas of interest include laboratory stewardship and laboratory informatics. He is particularly interested in establishing efficient production workflows in toxicology testing to meet the growing testing demands in his laboratory.

Education and training

  • Degrees

    • Ph.D., 2013, University of California, San Diego

  • Fellowship

    • COMACC Clinical Chemistry Fellowship, University of California, San Diego, 2013-2015

  • Certifications

    • Clinical Chemistry (ABCC, CC), 2015
    • Subspecialty Board in Toxicological Chemistry (ABCC, TC), 2016

Publications

Elsevier pure profile

Selected publications

  • 1. Saitman, A. “Clinical Drug Testing Supporting Patients with Substance Use Disorder: A Review.” JALM. 2025, 1;10:1-16.
  • 2. Liao H-C.; Saitman, A.; Dickerson, J. “Developing Benchmarking Metrics for Appropriate Ordering of Vitamin D, Thyroid Testing, and Iron Workups.” JALM. 2025, 1;10:184-91.
  • 3. Saitman, A. “How the VALID Act Could Affect Patient Access to Laboratory Developed Testing for Therapeutic Drug Monitoring.” JMSACL. 2023, 1;28:56-9.
  • 4. Brister-Smith, A.; Young, J.; Saitman, A. “A 24-Hour Extended Calibration Strategy for Quantitating Tacrolimus Concentrations by Liquid Chromatography–Tandem Mass Spectrometry.” JALM. 2021, 6(5), 1293-1298.
  • 5. Saitman, A. “Overview of Analytical Methods in Drugs of Abuse Analysis: Gas Chromatography/Mass Spectrometry, Liquid Chromatography Combined with Tandem Mass Spectrometry and Related Methods (Book Chapter).” 2nd Ed. Critical Issues in Alcohol and Drugs of Abuse Testing. 2018, ISBN 0128156070.
  • 6. Wright, A.; Young, J.; Smith, B.; Saitman, A. “Case of the Missing Metabolite: How Unexpected Urine Drug Metabolite Patterns May Lead to False Interpretations.” Clin Chem. 2018, 64(9), 1291-1293.
  • 7. Woods, G. N.; Saitman, A.; Gao, H.; Clarke. N. J.; Fitzgerald, R. L.; Chi, N-W.  “A Young Woman with Recurrent Gestational Hypercalcemia and Acute Pancreatitis due to CYP24A1 Deficiency.” J Bone Miner Res. 2016, 31(10), 1841-1844.
  • 8. Saitman, A.; Metushi, I. G.; Mason, D. S. Fitzgerald, R. L. “Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay.” Ther Drug Monit. 2016, 38(3), 300-304.
  • 9. O’Connell, C. W.; Sadler, C.; Saitman, A.; Tolia, V.; Fitzgerald, R. L.; Ly, B. T. “Overdose of etizolam: The abuse and rise of a "research chemical"” Ann Emerg Med. 2015, 65, 465-466.
  • 10. Saitman, A.; Park, HD.; Fitzgerald, R. L. “False positive interferences of common urine drug screen immunoassays: A review.” J. Anal. Toxicol. 2014, 38(7), 387-396.